Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year debt growth rate
Percentile
P18
Within normal range
vs 5Y Ago
-0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.91% |
| Q3 2025 | 231.70% |
| Q2 2025 | -67.89% |
| Q1 2025 | 25.55% |
| Q4 2024 | -32.72% |
| Q3 2024 | 23.62% |
| Q2 2024 | -6.27% |
| Q1 2024 | -2.84% |
| Q4 2023 | -6.36% |
| Q3 2023 | -4.49% |
| Q2 2023 | 17.83% |
| Q1 2023 | -23.41% |
| Q4 2022 | 17.41% |
| Q3 2022 | -4.57% |
| Q2 2022 | 266.69% |
| Q1 2022 | -38.27% |
| Q4 2021 | 15.04% |
| Q3 2021 | 101.72% |
| Q2 2021 | -3.08% |
| Q1 2021 | -16.35% |
| Q4 2020 | 14.45% |
| Q3 2020 | -2.17% |
| Q2 2020 | -2.82% |
| Q1 2020 | -12.14% |
| Q4 2019 | 8.15% |
| Q3 2019 | -2.59% |
| Q2 2019 | 3.34% |
| Q1 2019 | 0.00% |
| Q4 2018 | -100.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |